Advancing Immunopeptidomics: Meet the Experts Behind the Conference

Senior Scientists & Scientific Group Leaders
Pharmaceutical & Biotechnology Industry
The conference brings together senior scientists and scientific group leaders from global pharmaceutical and biotechnology organizations. These attendees are actively engaged in advancing immunopeptidomics workflows, biomarker discovery, and immune monitoring strategies within both research and clinical development environments.

Immunopeptidomics & Proteomics Specialists
Participants include experts specializing in:
HLA ligand identification and annotation
Mass spectrometry–based proteomics
Data analysis and immunopeptidome interpretation
Translational immunology research
Their combined expertise enables in-depth discussion around experimental design, analytical challenges, and real-world applications of immunopeptidomics technologies.

Academic & Translational Researchers
The session also welcomes academic researchers and translational scientists working at the interface of basic immunology and clinical application. These attendees contribute perspectives on how immunopeptidomics can be leveraged to better understand disease mechanisms and support the development of targeted immunotherapies.

What to Expect from the Discussion
During the conference , attendees will explore:
Advances in HLA-peptidomics technology
Best practices for immunopeptidomics data generation and analysis
Applications in oncology, infectious disease, and immune-mediated disorders
How platforms like HLA-Compass support deeper immune insight
The discussion is designed to be both scientifically rigorous and highly practical, offering valuable insights for researchers across academia and industry.